^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
PX-478
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Pfizer
Drug class:
HIF-1α inhibitor
Related drugs:
Phase 1
Cascadian Therapeutics Inc.
Completed
Last update posted :
05/17/2018
Initiation :
08/01/2007
Primary completion :
05/01/2010
Completion :
05/01/2010
HIF1A
|
PX-478
Share
